Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aclairo Pharmaceutical Development Group

Aclairo Pharmaceutical Development Group
2004 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of pharmaceutical consulting services. The company offers pharmaceutical development, non-clinical and pre-clinical project management, strategic, scientific and regulatory services to the healthcare, pharmaceutical and drug device industries.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Other Healthcare
Parent Company
Experimental Pathology Laboratories
Primary Office
  • 1950 Old Gallows Road
  • Suite 300
  • Vienna, VA 22182
  • United States

+1 (703) 000-0000

Aclairo Pharmaceutical Development Group Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Aclairo Pharmaceutical Development Group‘s full profile, request access.

Request full access to PitchBook

Aclairo Pharmaceutical Development Group Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ProMedDx Private Equity-Backed Norton, MA 000000000000
00000000000 0000 Private Equity-Backed Durham, NC 000 0000 000000000000 0000
To view this company’s complete list of competitors, request access »

Aclairo Pharmaceutical Development Group Executive Team (2)

Name Title Board
Seat
Contact
Info
Hilary Sheevers Ph.D Co-Founder, Senior Managing Consultant, President & Chief Executive Officer
Susan Wilson Ph.D Co-Founder, Vice President, Senior Managing Consultant & Chief Scientific Officer